Top Markets
#1 DogBull DogBull +132.53%
#2 Harmony Harmony +116.31%
#3 Akedo Akedo +56.16%
#4 Zama Zama +46.52%
#5 Bedrock Bedrock +42.53%
#6 Derive Derive +33.60%
#7 Celer Network Celer Network +33.47%
#8 Gravity Gravity +30.25%
#9 Epic Chain Epic Chain +27.76%
#10 OpenServ OpenServ +27.30%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
GSK plc GSK plc

GSK plc

GSK
Rank in Stocks #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Share Price
$25.28
Last synced: 2026-09-18
Market Cap
$1.01B
Change (1 day)
-2.29%
Change (1 year)
-37.84%
Country
GB
Trade GSK plc (GSK)

Category

Healthcare
Earnings for GSK plc (GSK)
Earnings in Jun 2026 TTM: $8.03B
According to GSK plc latest financial reports the company's current earnings are $8.03B. In 2024 the company made an earning of $4.36B, a decrease compared to its 2023 earnings that were of $7.72B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GSK plc from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $8.03B -17.47%
2025 $9.73B 123.11%
2024 $4.36B -43.48%
2023 $7.72B 13.38%
2022 $6.81B 39.93%
2021 $4.87B -31.16%
2020 $7.07B -14.32%
2019 $8.25B 34.93%
2018 $6.11B 28.34%
2017 $4.76B 99.06%
2016 $2.39B -84.57%
2015 $15.51B 235.45%
2014 $4.62B -58.00%
2013 $11.01B 2.83%
2012 $10.71B -10.38%
2011 $11.95B 143.12%
2010 $4.91B -61.53%
2009 $12.77B 31.37%
2008 $9.72B -35.26%
2007 $15.02B -1.77%
2006 $15.29B 31.99%
2005 $11.58B 4.33%
2004 $11.10B -1.73%
2003 $11.30B 27.36%
2002 $8.87B 0.26%
2001 $8.85B -1.72%
2000 $9.00B 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B 318.17%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B 213.63%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B 8.28%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B 166.24%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -25.96%
US